🇺🇸 FDA
Pipeline program

PREDNISONE, PREDNISONE , HYDROXYCHLOROQUINE

APHP191105

Phase 3 small_molecule active

Quick answer

PREDNISONE, PREDNISONE , HYDROXYCHLOROQUINE for Sarcoidosis is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Sarcoidosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials